These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hemodynamic improvement as an additional parameter to evaluate the safety and tolerability of the molecular adsorbent recirculating system in liver failure patients. Pugliese F; Novelli G; Poli L; Levi Sandri GB; Di Folco G; Ferretti S; Morabito V; Ruberto F; Berloco PB Transplant Proc; 2008; 40(6):1925-8. PubMed ID: 18675091 [TBL] [Abstract][Full Text] [Related]
4. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Laleman W; Wilmer A; Evenepoel P; Elst IV; Zeegers M; Zaman Z; Verslype C; Fevery J; Nevens F Crit Care; 2006; 10(4):R108. PubMed ID: 16859530 [TBL] [Abstract][Full Text] [Related]
5. Effects of different vasopressors on hemodynamics in patients undergoing orthotopic liver transplantation. Zhang LP; Li M; Yang L Chin Med J (Engl); 2005 Dec; 118(23):1952-8. PubMed ID: 16336830 [TBL] [Abstract][Full Text] [Related]
6. Results of treatment of acute liver failure patients with use of the prometheus FPSA system. Grodzicki M; Kotulski M; Leonowicz D; Zieniewicz K; Krawczyk M Transplant Proc; 2009 Oct; 41(8):3079-81. PubMed ID: 19857681 [TBL] [Abstract][Full Text] [Related]
7. Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs. Gaspari R; Cavaliere F; Sollazzi L; Perilli V; Melchionda I; Agnes S; Gasbarrini A; Avolio AW Transplant Proc; 2009; 41(1):253-8. PubMed ID: 19249528 [TBL] [Abstract][Full Text] [Related]
8. Molecular adsorbent recirculating system in liver transplantation: Safety and efficacy. Gaspari R; Avolio AW; Zileri Dal Verme L; Agnes S; Proietti R; Castagneto M; Gasbarrini A Transplant Proc; 2006 Dec; 38(10):3544-51. PubMed ID: 17175327 [TBL] [Abstract][Full Text] [Related]
9. Predictive parameters after molecular absorbent recirculating system treatment integrated with model for end stage liver disease model in patients with acute-on-chronic liver failure. Novelli G; Rossi M; Ferretti G; Pugliese F; Travaglia D; Guidi S; Novelli S; Lai Q; Morabito V; Berloco PB Transplant Proc; 2010 May; 42(4):1182-7. PubMed ID: 20534256 [TBL] [Abstract][Full Text] [Related]
10. Hyperdynamic circulation in acute liver failure: reperfusion syndrome and outcome following liver transplantation. Siniscalchi A; Dante A; Spedicato S; Riganello L; Zanoni A; Cimatti M; Pierucci E; Bernardi E; Miklosova Z; Moretti C; Faenza S Transplant Proc; 2010 May; 42(4):1197-9. PubMed ID: 20534260 [TBL] [Abstract][Full Text] [Related]
11. One hundred sixteen cases of acute liver failure treated with MARS. Novelli G; Rossi M; Pretagostini M; Pugliese F; Ruberto F; Novelli L; Nudo F; Bussotti A; Corradini S; Martelli S; Berloco PB Transplant Proc; 2005; 37(6):2557-9. PubMed ID: 16182742 [TBL] [Abstract][Full Text] [Related]
12. Predictive criteria for the outcome of patients with acute liver failure treated with the albumin dialysis molecular adsorbent recirculating system. Novelli G; Rossi M; Ferretti G; Pugliese F; Ruberto F; Lai Q; Novelli S; Piemonte V; Turchetti L; Morabito V; Annesini MC; Berloco PB Ther Apher Dial; 2009 Oct; 13(5):404-12. PubMed ID: 19788457 [TBL] [Abstract][Full Text] [Related]
13. Management of sepsis during MARS treatment in acute on chronic liver failure. Novelli G; Morabito V; Pugliese F; Ferretti G; Novelli S; Ianni S; Lai Q; Rossi M; Berloco PB Transplant Proc; 2011 May; 43(4):1085-90. PubMed ID: 21620059 [TBL] [Abstract][Full Text] [Related]
14. Pulse contour cardiac output system use in pediatric orthotopic liver transplantation: preliminary report of nine patients. Torgay A; Pirat A; Akpek E; Zeyneloglu P; Arslan G; Haberal M Transplant Proc; 2005 Sep; 37(7):3168-70. PubMed ID: 16213339 [TBL] [Abstract][Full Text] [Related]
15. [Improved kidney function with intravenous prostaglandin E1 in patients with terminal heart failure]. Wutte M; Hülsmann M; Berger R; Rödler S; Frey B; Stanek B; Pacher R Wien Klin Wochenschr; 1998 Jul; 110(13-14):473-8. PubMed ID: 9746960 [TBL] [Abstract][Full Text] [Related]
16. Morbidity and mortality in liver retransplantation. Alamo JM; Gómez MA; Pareja F; Martínez A; López F; Romero E; Barrera L; Serrano J; García I; Bernardos A Transplant Proc; 2006 Oct; 38(8):2475-7. PubMed ID: 17097972 [TBL] [Abstract][Full Text] [Related]
17. Hemodynamic parameters in patients with acute cervical cord trauma: description, intervention, and prediction of outcome. Levi L; Wolf A; Belzberg H Neurosurgery; 1993 Dec; 33(6):1007-16; discussion 1016-7. PubMed ID: 8133985 [TBL] [Abstract][Full Text] [Related]
19. [Impact of pulmonary hypertension on early hemodynamics after orthotopic heart transplantation]. Liu MZ; Wang JH; Du J; Huang J; Li LH Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2618-22. PubMed ID: 18162149 [TBL] [Abstract][Full Text] [Related]
20. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure. Mitzner SR; Stange J; Klammt S; Peszynski P; Schmidt R; Nöldge-Schomburg G J Am Soc Nephrol; 2001 Feb; 12 Suppl 17():S75-82. PubMed ID: 11251037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]